Report Highlights
The global market for prescription drugs to treat mental health disorders was valued at $53.9 billion in 2025, and it is estimated to increase from $56.5 billion in 2026 to reach $77.8 billion by 2031, at a compound annual growth rate (CAGR) of 6.6% from 2026 through 2031.
Report Includes
- 26 data tables and 58 additional tables
- An overview of the global market for pharmaceutical treatments for mental health disorders
- In-depth analyses of global market trends, featuring historical revenue data from 2022 to 2025, 2026, and forecasts through 2031. The analysis includes projections of compound annual growth rates (CAGRs) through 2031
- Estimation of the market size and evaluation of the global mental health disorders pharmaceuticals market by condition and geographic region
- Coverage of major conditions including attention-deficit/hyperactivity disorder (ADHD), depression and anxiety disorders, substance use disorders, and schizophrenia
- Discussion of significant market drivers, restraints, challenges and opportunities affecting the mental health disorders pharmaceuticals market
- Analysis of emerging technologies, trends and developments, along with insights from clinical trial analysis and emerging therapies
- Assessment of the competitive landscape, including market share and ranking of key players and strategic analysis of the industry
- Profiles of leading companies in the market including, Johnson & Johnson, AbbVie, Takeda Pharmaceutical Co. Ltd., Otsuka Pharmaceutical Co. Ltd., and H. Lundbeck A/S.
Report Scope
This report presents an in-depth analysis of the global market for pharmaceuticals to treat mental health disorders, including clinical depression and anxiety disorders, attention-deficit/hyperactivity disorder (ADHD), schizophrenia, and substance use disorder (SUD), by conditions, drug type, and geographic markets. The regions covered in this study include North America, Europe, Asia-Pacific, Middle East and Africa, and South America, with a focus on major countries in each region.
BCC Research estimates market data for 2025 (the base year) and forecasts values for 2026 through 2031. The report focuses on the major trends, challenges, and opportunities in the market and vendor landscape. It also covers new product launches, acquisitions, and collaborations related to the market. The report also includes an in-depth analysis of the competitive landscape, emerging drug classes, and profiles of the leading companies.
Report Synopsis
| Report Metrics | Details | ||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Base year considered | 2025 | ||||||||||||||||
| Forecast period considered | 2026-2031 | ||||||||||||||||
| Base year market size | $53.9 Billion | ||||||||||||||||
| Market size forecast | $77.8 Billion | ||||||||||||||||
| Growth rate | CAGR of 6.6% for the forecast period of 2026-2031 | ||||||||||||||||
| Units considered | $ Millions | ||||||||||||||||
| Segments covered | By Disorder Type, By Drug Type, By Region | ||||||||||||||||
| Regions covered | North America, Europe, Asia-Pacific, South America, and Middle East and Africa | ||||||||||||||||
| Countries covered | U.S., Canada, Mexico, Germany, U.K., France, Italy, Spain, Switzerland, Denmark, Norway, Poland, Belgium, Austria, Netherlands, Sweden, Russia, China, Japan, Australia, India, South Korea, New Zealand, Taiwan, Singapore, Malaysia, Thailand, Philippines, and Indonesia | ||||||||||||||||
| Key Market Drivers |
|
||||||||||||||||
| Companies studied |
|
||||||||||||||||
Frequently Asked Questions (FAQs)
- Widespread global prevalence of mental health disorders.
- Rising awareness and declining stigma driving improved diagnosis of mental health disorders.
- Advancements in drug development and novel mechanisms of action.
- Expansion of healthcare access and insurance coverage.
- Key challenges include- Low treatment penetration despite high disease burden; Poor treatment adherence and high discontinuation rates; Drug shortages.
- Key Opportunities include- Shift toward long-acting and extended -release therapies; Growing focus on treatment-resistant mental health conditions; Integration of digital therapeutics with pharmacotherapy
Analyst Credentials
BCC Research Team possesses expertise and experience in life and physical science domains. They specialize in offering valuable business insights, including industry analysis, competitor intelligence, strategic and financial analysis, and opportunity assessment. The team has in-depth knowledge of various sectors, including healthcare, biotechnology, pharmaceuticals, IT, automation, advanced materials, and energy. They are proficient in qualitative and quantitative market intelligence providing clients with actionable insights. With a vast understanding of the competitive landscape, the team can support clients in making data-driven decisions to help them achieve a competitive edge in their respective markets.
Related Reports
Substance Use Disorder Treatment: Global Markets to 2030
The global substance use disorder (SUD) treatment market was valued at $11.6 billion in 2025, and it is expected to reach $14.6 billion by the end of 2030, at a compound annual growth rate (CAGR) of 4.6% from 2025 to 2030.
Cannabis Market: Products, Technologies, and Applications
The global market for cannabis was valued at $45.6 billion in 2025 and is projected to reach $79.3 billion by the end of 2030, at a compound annual growth rate (CAGR) of 11.7% during the forecast period of 2025 to 2030.
Mental Health Application: Technologies and Global Markets
The global market for mental health applications was valued at $2.5 billion in 2022. The market is estimated to grow from $3.0 billion in 2023 to $6.5 billion by 2028, at a compound annual growth rate (CAGR) of 16.6% from 2023 to 2028.
Track the Latest Global Tariff Developments
In today's fast-paced global economy, tariffs are no longer static—they are dynamic levers shaped by geopolitical realignments, supply chain vulnerabilities, inflationary pressures, and sustainability-driven trade reforms. As governments worldwide recalibrate their trade strategies, businesses are left to navigate a maze of shifting rules, rising costs, and regulatory uncertainty.
Our analysis empowers you with real-time updates and in-depth expert analysis on all facets of global tariff activity. From new trade agreements and sanctions to abrupt tariff hikes and retaliatory duties, we monitor developments across borders, sectors, and industries—so you don't have to.
Whether it's the ongoing U.S.–China trade dynamics, the evolving EU Carbon Border Adjustment Mechanism (CBAM), or the emerging policies in India, ASEAN, and Latin America, we provide full-spectrum coverage. We also track multilateral trade negotiations, World Trade Organization (WTO) rulings, and sector-specific duty structures—ensuring you are always ahead of global trade shifts.
With our analysis, you can stay informed, identify risks, and confidently respond to tariff changes—no matter where you operate.
Ready to see what tariff means for your business?
Consult with our experts or request your custom Tariff Impact Brife today
Stay Informed, Stay Competitive
In today's interconnected and unpredictable global economy, staying ahead of tariff shifts is not just important—it's essential. BCC Research provides decision-makers with trusted, research-driven insights that turn uncertainty into opportunity.
Our in-depth market analysis and trade intelligence help you decode how tariff changes impact your specific sector—manufacturing, healthcare, technology, agriculture, or energy. We break down complex data into actionable knowledge through comprehensive reports, expert commentaries, and sector-focused forecasts.
Our analysis includes:
- Thorough breakdowns of current and proposed tariff policies and how they affect regional and global trade flows.
- Sector-specific implications, helping you understand the strategic impact on sourcing, pricing, and competitiveness.
- Forward-looking insights to support risk management, planning, and response strategies for evolving trade conditions.
With BCC Research, you gain more than just information—you gain clarity and confidence to make well-informed decisions in a volatile trade environment.
Don't let tariffs catch you off guard—let our insights guide your strategy.
Recent Reports
Pharmaceutical Treatments for Mental Health Disorders: Global Markets
The global market for prescription drugs to treat mental health disorders was valued at $53.9 billion in 2025, and it is estimated to increase from $56.5 billion in 2026 to reach $77.8 billion by 2031, at a compound annual growth rate (CAGR) of 6.6% from 2026 through 2031.
Global Vaccine Adjuvants Market
This report provides an analysis of the global market for vaccine adjuvants. It focuses on the key driving trends and challenges. The study evaluates the competitive landscape, reviews key technological developments, and provides market estimates and forecasts through 2031.
Global Topical Drug Delivery Market
The global topical drug delivery market was valued at $222.9 billion in 2025 and is estimated to increase from $239 billion in 2026 to reach $362.3 billion by the end of 2031, at a compound annual growth rate (CAGR) of 8.7% from 2026 to 2031.
Blood Cancer Therapeutics: Global Markets to 2030
The global market for blood cancer therapeutics was valued at $77.1 billion in 2025 and is projected to reach $125.5 billion by the end of 2030, at a compound annual growth rate (CAGR) of 10.2% from 2025 to 2030.
Clinical Nutrition: Global Markets to 2031
The global market for clinical nutrition is expected to grow from $79.5 billion in 2026 and is projected to reach $104.7 billion by the end of 2031, at a compound annual growth rate (CAGR) of 5.6% during the forecast period of 2026 to 2031.
Top Trending Reports
Bioinformatics: Technologies and Global Markets
The global bioinformatics market was valued at $23.5 billion in 2025 and is estimated to reach $43.5 billion by the end of 2030, at a compound annual growth rate (CAGR) of 13.1% from 2025 to 2030.
Validation, Calibration, and Standardization in the Life Sciences Market
The global market for validation, calibration, and standardization in life sciences was valued at $2.8 billion in 2025 and is estimated to reach $3.9 billion by 2030, at a compound annual growth rate (CAGR) of 6.7% from 2025 through 2030.
Global Enterprise Artificial Intelligence (AI) Market
This study examines the global enterprise AI market across key segments such as component, software deployment, technology, organization size, end user and geography. It focuses on commercially deployed AI software, services and hardware generating revenue across industries, including new deployments and the expansion of existing AI infrastructure. The analysis also covers emerging technologies, major market trends and challenges, the competitive landscape and profiles of leading companies. Regional market trends are assessed using 2025 as the base year, with forecasts from 2026 through 2031.
Outpatient Surgical Procedures: Global Markets
The global market for outpatient surgical procedures is expected to grow from $381.9 billion in 2026 and is projected to reach $598.6 billion by the end of 2031, at a compound annual growth rate (CAGR) of 9.4% during the forecast period of 2026 to 2031.
Global Vaccine Adjuvants Market
This report provides an analysis of the global market for vaccine adjuvants. It focuses on the key driving trends and challenges. The study evaluates the competitive landscape, reviews key technological developments, and provides market estimates and forecasts through 2031.
Report Highlights
The global market for drugs prescribed to treat mental health disorders should grow from $49.4 billion in 2020 to $62.6 billion by 2025 with a compound annual growth rate (CAGR) of 4.8% for the period of 2020-2025.
Report Includes
- 46 data tables and 12 additional tables
- An overview of the global markets for pharmaceutical treatments for mental health disorders
- Analyses of market trends, with data from 2019, 2020 and projections of compound annual growth rates (CAGRs) through 2025
- Evaluation of current market trends, market size, market forecast, pipeline analysis of new products, and regulatory scenarios and detailed analysis of drivers, challenges, and opportunities affecting market growth
- Description of biological factors such as anatomical, chemical and genetic traits, and psychological reasons such as conflict or trauma on the mental health and discussion on effect of COIVD-19 pandemic, social distancing and social isolation on the mental health conditions
- A look at the markets for treatment of psychiatric disorders such as depression, anxiety and obsessive-compulsive disorder (OCD) and their co relation with COVID-19
- Details of technological advances and improvement in the development of pharmacological treatments, digital therapeutics (DTx) and cognitive behavioural therapy (CBT)
- Information on tele mental health software such as ReSet, Pears Somryst and Alkili’s EndeavorRx which offers personalized treatment strategies and behavioural healthcare platform which plays an important role in the management of mental health disorders
- Snapshot of leading mental health conditions, and products in phase III development for selected psychiatric disorders
- Analysis of recent product developments including pharmacological and digital therapeutics, late-stage pipeline products and points of differentiation from existing therapies
- Market share analysis of the key companies of the industry, their strategic profiling, their competitive landscape and their detailed company profiles including, Eli Lilly, Johnson & Johnson, Pfizer, Takeda, and Shionogi
Become A Member
BCC Research offers a comprehensive library of reports, granting members unlimited access to data, insights, and market intelligence for informed business decisions, while actively supporting members in their evolving journeys and prioritizing high-quality, relevant topics based on continuous engagement with the research community.
Find Out MoreCustom Consulting
BCC Research emphasizes the importance of organizations leveraging highly customized market insights aligned with specific strategic business objectives through direct engagement with primary sources and proprietary forecasting models for profitable decision-making in maximizing growth opportunities and minimizing risks.
Customize NowScorecard
The Venture Scorecard provides commercialization offices and decision makers with expert analysis, offering strategic insights crucial for aligning objectives with market realities at various stages of commercializing new products or evaluating investment opportunities, from opportunity assessment to growth planning.
Find Out MoreInnovation Spotlight
Our industry experts offer strategic guidance to maximize the market potential of commercialized products, patents, and IP by providing insights into market trends, competitive dynamics, and effective positioning, using the Innovation Spotlight service for enhanced exposure to thought leaders and the wider community.
Find Out More